Crexendo Non-GAAP EPS of $0.12 beats by $0.03, revenue of $25.2M beats by $0.06M

Seeking Alpha · November 3, 2026, 21:02 UTC

Topics: earnings non-gaap_eps revenue

Read the full article at Seeking Alpha

Part of the story UroGen Pharma Reports Strong Revenue Growth Driven by Zosturi Sales (7 articles)

More World news

AiPrise Launches Token Sharing Infrastructure to Streamline Compliance Verification PR Newswire · November 12, 2026, 19:39 UTC
Barclays Upgrades Steel Producers Cleveland-Cliffs and Reliance Amid Market Selloff Seeking Alpha · November 12, 2026, 19:32 UTC
Mercantile Bank Announces New Full-Service Banking Center in Holland, Michigan PR Newswire · November 12, 2026, 19:28 UTC
Broadwind Reports 48% Revenue Growth and Record Industrial Solutions Backlog in Q3 2026 Motley Fool · November 12, 2026, 19:25 UTC
MediWound Reports Q3 2026 Financial Results Amid Clinical Trial Expansion Motley Fool · November 12, 2026, 19:25 UTC
Twist Bioscience Reports Q4 2026 Revenue Growth and First Positive Adjusted EBITDA Motley Fool · November 12, 2026, 19:25 UTC
Chicago Atlantic BDC Reports Q3 2026 Growth in Net Investment Income and Record Portfolio Value Motley Fool · November 12, 2026, 19:25 UTC
Google Integrates Gemini 4 Hydrogen Model into Search to Enhance Complex Query Handling TechCrunch · November 12, 2026, 19:27 UTC
General Motors Partners with NorthStar Clean Energy for Large-Scale Solar Project in Michigan Seeking Alpha · November 12, 2026, 19:24 UTC
CNBC Select Names Accredited Debt Relief Best for Debt Resources PR Newswire · November 12, 2026, 19:25 UTC